In the afternoon of February 5, Wang Jiaohu, Secretary of the District Party Committee, Lin Xia, Deputy Secretary of the District Party Committee and Head of the District, and his delegation went to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. to send congratulatory letters to them, congratulating the company on the antiviral drug "ribavirin" being included in the Diagnosis and Treatment Plan for Pneumonia Infected with novel coronavirus (Trial Version 5).
"At a time when people all over the country are united in fighting against the epidemic, I am glad to hear that the antiviral drug" ribavirin "produced by your company has been included in the Diagnosis and Treatment Plan for Pneumonia Infected by novel coronavirus (Trial Version 5). I would like to extend warm congratulations and sincere respect to all employees of the company." Wang Jiaohu said.
Wang Jiaohu said that Zheng Cheng Yi Pharmaceutical Co., Ltd. has been rooted on the island for more than 50 years and has always been a star enterprise in Dongtou, making positive contributions to the economic and social development of our region. Especially in recent years, the company has been committed to high-quality development and increased its efforts in technological innovation, becoming the first listed company in our province in the field of marine biology and pharmaceutical innovation. It has also established the "Three Centers" in Shanghai, achieving a leap from "offshore" to Shanghai, and has won widespread praise from all sectors of society.
Wang Jiaohu hopes that Cheng Yi Pharmaceutical will continue to carry forward the spirit of Dongtou, utilize the opportunity of drugs being included in the trial plan for diagnosis and treatment, increase its efforts to ensure production and supply, and make new and greater contributions to winning this war "epidemic" nationwide.
Source: Dongtou News Network